Department of Gynecology and Obstetrics, Yantai Affiliated Hospital of Binzhou Medical University, Muping District, Yantai, Shandong 264100, China.
Comput Math Methods Med. 2022 Jul 4;2022:1418232. doi: 10.1155/2022/1418232. eCollection 2022.
Long noncoding RNA (lncRNA) has received more and more attention in human tumor research. This study is aimed at clarifying the regulatory network of lncRNAs-microRNAs- (miRNAs-) mRNAs and at determining the relevant targets in the development of endometrial cancers.
Download the miRNA, mRNA, and lncRNA expression profile data of endometrial cancer patients from TCGA; use the "DESeq2" package of R software to identify the differential expression of miRNAs, mRNAs, and lncRNAs; construct a network of ceRNA; and perform gene ontology (GO) and Kyoto Encyclopedia of Gene and Genome (KEGG) pathway enrichment assessment on mRNAs in the network of ceRNA; string and Cytoscape 3.7.2 perform PPI assessment on target genes and TOP 10 hub gene screening; Cytoscape 3.7.2 computer program was employed for constructing the lncRNA-miRNA-TOP10 hub mRNA network diagram to determine the signal axis; StarBase database to verify the Top10 hub mRNA expression; the "survival" package in R computer program was implemented to analyze the survival rate of all genes on the lncRNA-miRNA-Top10 hub mRNA network diagram; RT-qPCR to verify the expression level of genes on the signal axis.
1119 differential mRNAs, 14 differential lncRNAs, and 65 differential miRNAs were screened in TCGA; we constructed a ceRNA regulatory network composed of 5 DELs, 7 DEMs, and 90 DEGs; String combined with Cytoscape to screen out Top10 hub genes, namely: LEFTY1, LIN28A, LHX3, ST8SIA3, CEP55, FBXO32, DCN, ANGPTL1, ADRA1A, and KCNMA1; the StarBase database verification results show that ADRA1A, ANGPTL1, FBXO32, KCNMA1, and DCN are downregulated in endometrial cancer tissues; LEFTY1, LIN28A, LHX3, ST8SIA3, and CEP55 are upregulated in endometrial cancer; the constructed lncRNA-miRNA-hub Top10 mRNA network map identified CTD-2314B22, RP11-89 K21/hsa-miR-143, hsa-miR-424/LEFTY1, LIN28A, LHX3, ST8SIA3, and CEP55 signal axis; survival analysis results show that CTD-2314B22, RP11-89 K21, hsa-miR-96, hsa-miR-211, LHX3, ST8SIA3, and DCN are all related to survival; RT-qPCR results indicate CTD-2314B22, RP11-89 K21, LEFTY1, LIN28A, LHX3, ST8SIA3, and CEP55 are upregulated in endometrial cancer cells, and hsa-miR-143 and hsa-miR-424 are downregulated in endometrial cancer cells.
From the perspective of the lncRNA-miRNA-mRNA network, our study identified CTD-2314B22, RP11-89 K21/hsa-miR-143, hsa-miR-424/LEFTY1, LIN28A, LHX3, ST8SIA3, and CEP55 signal axis, which can present considerably potent biomarkers and therapeutic targets for treating endometrial cancer.
长链非编码 RNA(lncRNA)在人类肿瘤研究中受到越来越多的关注。本研究旨在阐明 lncRNA-miRNA-mRNA 的调控网络,并确定子宫内膜癌发展过程中的相关靶点。
从 TCGA 下载子宫内膜癌患者的 miRNA、mRNA 和 lncRNA 表达谱数据;使用 R 软件的“DESeq2”包识别 miRNA、mRNA 和 lncRNA 的差异表达;构建 ceRNA 网络;对 ceRNA 网络中的 mRNAs 进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集评估;STRING 和 Cytoscape 3.7.2 对靶基因进行 PPI 评估和 TOP10 枢纽基因筛选;Cytoscape 3.7.2 计算机程序用于构建 lncRNA-miRNA-TOP10 枢纽 mRNA 网络图,以确定信号轴;StarBase 数据库验证 Top10 枢纽 mRNA 表达;R 计算机程序中的“survival”包用于分析 lncRNA-miRNA-TOP10 枢纽 mRNA 网络图上所有基因的生存率;RT-qPCR 验证信号轴上基因的表达水平。
TCGA 筛选出 1119 个差异表达的 mRNAs、14 个差异表达的 lncRNAs 和 65 个差异表达的 miRNAs;构建了一个由 5 个 DELs、7 个 DEMs 和 90 个 DEGs 组成的 ceRNA 调控网络;STRING 结合 Cytoscape 筛选出 TOP10 枢纽基因,即:LEFTY1、LIN28A、LHX3、ST8SIA3、CEP55、FBXO32、DCN、ANGPTL1、ADRA1A 和 KCNMA1;StarBase 数据库验证结果表明,ADRA1A、ANGPTL1、FBXO32、KCNMA1 和 DCN 在子宫内膜癌组织中下调;LEFTY1、LIN28A、LHX3、ST8SIA3 和 CEP55 在子宫内膜癌中上调;构建的 lncRNA-miRNA-枢纽 Top10 mRNA 网络图谱确定了 CTD-2314B22、RP11-89 K21/hsa-miR-143、hsa-miR-424/LEFTY1、LIN28A、LHX3、ST8SIA3 和 CEP55 信号轴;生存分析结果表明,CTD-2314B22、RP11-89 K21、hsa-miR-96、hsa-miR-211、LHX3、ST8SIA3 和 DCN 均与生存相关;RT-qPCR 结果表明,CTD-2314B22、RP11-89 K21、LEFTY1、LIN28A、LHX3、ST8SIA3 和 CEP55 在子宫内膜癌细胞中上调,而 hsa-miR-143 和 hsa-miR-424 在子宫内膜癌细胞中下调。
从 lncRNA-miRNA-mRNA 网络的角度来看,我们的研究确定了 CTD-2314B22、RP11-89 K21/hsa-miR-143、hsa-miR-424/LEFTY1、LIN28A、LHX3、ST8SIA3 和 CEP55 信号轴,这些信号轴可以作为治疗子宫内膜癌的潜在生物标志物和治疗靶点。